Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H33O5.Na |
| Molecular Weight | 424.5056 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].C[C@H](CCC([O-])=O)[C@H]1CC[C@H]2[C@H]3[C@H](CC(=O)[C@]12C)[C@@]4(C)CCC(=O)C[C@H]4CC3=O
InChI
InChIKey=FKJIJBSJQSMPTI-CAOXKPNISA-M
InChI=1S/C24H34O5.Na/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26;/h13-14,16-18,22H,4-12H2,1-3H3,(H,28,29);/q;+1/p-1/t13-,14+,16-,17+,18+,22+,23+,24-;/m1./s1
| Molecular Formula | C24H33O5 |
| Molecular Weight | 401.5158 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.drugs.com/dict/dehydrocholic-acid.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/6620121Curator's Comment: description was created based on several sources, including http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/5935948
Sources: http://www.drugs.com/dict/dehydrocholic-acid.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/6620121
Curator's Comment: description was created based on several sources, including http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/5935948
Sodium dehydrocholate is a hydrocholeretic and is used to study biliary excretion.
CNS Activity
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6877542
Curator's Comment: In rats, sodium dehydrocholate disrupts the blood-brain barrier for a period of over 3 days.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Anionic polypeptide fraction (APF) secretion in bile Sources: https://www.ncbi.nlm.nih.gov/pubmed/1502488 |
|||
Target ID: GO:0032782 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2340963 |
|||
Target ID: CHEMBL2714 |
|||
Target ID: Q99626 Gene ID: 1045.0 Gene Symbol: CDX2 Target Organism: Homo sapiens (Human) |
|||
Target ID: map04976 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2340963 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Decholinum Approved UseUnknown |
Doses
| Dose | Population | Adverse events |
|---|---|---|
250 mg 3 times / day multiple, oral Dose: 250 mg, 3 times / day Route: oral Route: multiple Dose: 250 mg, 3 times / day Sources: |
unhealthy, 36-75 Health Status: unhealthy Age Group: 36-75 Sex: M+F Sources: |
Other AEs: Nausea, Diarrhea... Other AEs: Nausea (1 patient) Sources: Diarrhea (1 patient) Weight loss (1 patient) Pain in hand (1 patient) |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Diarrhea | 1 patient | 250 mg 3 times / day multiple, oral Dose: 250 mg, 3 times / day Route: oral Route: multiple Dose: 250 mg, 3 times / day Sources: |
unhealthy, 36-75 Health Status: unhealthy Age Group: 36-75 Sex: M+F Sources: |
| Nausea | 1 patient | 250 mg 3 times / day multiple, oral Dose: 250 mg, 3 times / day Route: oral Route: multiple Dose: 250 mg, 3 times / day Sources: |
unhealthy, 36-75 Health Status: unhealthy Age Group: 36-75 Sex: M+F Sources: |
| Pain in hand | 1 patient | 250 mg 3 times / day multiple, oral Dose: 250 mg, 3 times / day Route: oral Route: multiple Dose: 250 mg, 3 times / day Sources: |
unhealthy, 36-75 Health Status: unhealthy Age Group: 36-75 Sex: M+F Sources: |
| Weight loss | 1 patient | 250 mg 3 times / day multiple, oral Dose: 250 mg, 3 times / day Route: oral Route: multiple Dose: 250 mg, 3 times / day Sources: |
unhealthy, 36-75 Health Status: unhealthy Age Group: 36-75 Sex: M+F Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Surgical outcome in relation to duct size at the porta hepatis and the use of cholagogues in patients with biliary atresia. | 2011-05-13 |
|
| Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes. | 2010-07 |
|
| Thermodynamic and elastic fluctuation analysis of Langmuir mixed monolayers composed by dehydrocholic acid (HDHC) and didodecyldimethylammonium bromide (DDAB). | 2010-01-01 |
|
| Study on bioactive compounds of in vitro cultured Calculus Suis and natural Calculus Bovis. | 2009-12 |
|
| Protective effect of bile acid derivatives in phalloidin-induced rat liver toxicity. | 2009-08-15 |
|
| Acidic and basic solutions dissolve protein plugs made of lithostathine complicating choledochal cyst/pancreaticobiliary maljunction. | 2009-07 |
|
| A new approach for diagnosis of hepatolithiasis: magnetic resonance cholangiopancreatography: potential usefulness of dehydrocholic acid (DHCA) administration in the evaluation of hepatolithiasis. | 2008-12-24 |
|
| Magnetic resonance cholangiopancreatography: potential usefulness of dehydrocholic acid (DHCA) administration in the evaluation of biliary disease. | 2008-07-11 |
|
| Magnetic resonance cholangiopancreatography: potential usefulness of dehydrocholic acid (DHCA) administration in the evaluation of anastomotic site. | 2008-05-30 |
|
| Spread mixed monolayers of deoxycholic and dehydrocholic acids at the air-water interface, effect of subphase pH. Characterization by axisymmetric drop shape analysis. | 2008-01 |
|
| Aqueous sodium dehydrocholate-sodium deoxycholate mixtures at low concentration. | 2007-10-15 |
|
| Determination of critical micellar concentrations of cholic acid and its keto derivatives. | 2007-10-01 |
|
| Regio- and stereoselective reductions of dehydrocholic acid. | 2006-06 |
|
| Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. | 2006-01 |
|
| A novel insulin derivative chemically modified with dehydrocholic acid: synthesis, characterization and biological activity. | 2005-08 |
|
| Sterol-derived hormone(s) controls entry into diapause in Caenorhabditis elegans by consecutive activation of DAF-12 and DAF-16. | 2004-10 |
|
| Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. | 2004-09-08 |
|
| Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats. | 2002-12 |
|
| Spasmocanulase in irritable bowel syndrome. | 2002-09 |
|
| Carbonic anhydrase inhibitors. Preparation of potent sulfonamides inhibitors incorporating bile acid tails. | 2002-06-17 |
|
| Choledocholithiasis in an infant of extremely low birthweight. | 2002-04 |
|
| Anodic electrochemical oxidation of cholic acid. | 2001-02 |
|
| Effects of sodium ursodeoxycholate, hyodeoxycholate and dehydrocholate on cholesterol and bile acid metabolism in rats. | 1983-05 |
|
| Influence of dehydrocholate sodium on the biliary reabsorption of sulfobromophtalein sodium from the rat biliary tree after retrograde intrabilary injection. | 1976-08-15 |
Sample Use Guides
The usual daily dose of dehydrocholic acid may be 250-750 mg per day, dehydrocholic acid may be administered in doses of 250 mg ingested once or twice per day, usually before meals or, for persons with sensitive gastrointestinal tracts, 125 mg two or three times per day before meals.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:35:58 GMT 2025
by
admin
on
Mon Mar 31 17:35:58 GMT 2025
|
| Record UNII |
W4193719XR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66913
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL514446
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
100000083547
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
C76604
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
DBSALT001944
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
145-41-5
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
SUB10556MIG
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
DTXSID00883335
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
m4142
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | Merck Index | ||
|
158
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
756707
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
W4193719XR
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
205-652-1
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY | |||
|
23675007
Created by
admin on Mon Mar 31 17:35:58 GMT 2025 , Edited by admin on Mon Mar 31 17:35:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |